Premium
SECOND‐STAGE TREATMENTS FOR RELATIVE NONRESPONDERS TO COGNITIVE BEHAVIORAL THERAPY (CBT) FOR PANIC DISORDER WITH OR WITHOUT AGORAPHOBIA—CONTINUED CBT VERSUS SSRI: A RANDOMIZED CONTROLLED TRIAL
Author(s) -
Payne Laura A.,
White Kamila S.,
Gallagher Matthew W.,
Woods Scott W.,
Shear M. Katherine,
Gorman Jack M.,
Farchione Todd J.,
Barlow David H.
Publication year - 2016
Publication title -
depression and anxiety
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.634
H-Index - 129
eISSN - 1520-6394
pISSN - 1091-4269
DOI - 10.1002/da.22457
Subject(s) - panic disorder , agoraphobia , citalopram , randomized controlled trial , cognitive behavioral therapy , paroxetine , discontinuation , panic , psychiatry , psychology , medicine , clinical psychology , antidepressant , anxiety
Cognitive behavioral therapy (CBT) and pharmacotherapy are efficacious for the short-term treatment of panic disorder. Less is known about the efficacy of these therapies for individuals who do not respond fully to short-term CBT.